Tag: raw materials

Mitigating API Assay Variability That Exceeds Trend Limits During Regulatory Inspections In the realm of pharmaceutical manufacturing, maintaining consistency and quality of Active Pharmaceutical Ingredients (APIs) is non-negotiable. Variability in…

Addressing API Assay Variability Beyond Trend Limits During a Deviation Investigation In pharmaceutical manufacturing, effective management of Active Pharmaceutical Ingredients (APIs) is crucial to maintaining product quality and regulatory compliance.…

Identifying and Addressing Impurity Profile Drift Following Supplier Changes In the dynamic environment of pharmaceutical manufacturing, changes to raw material suppliers can have significant impacts on product quality. One critical…

Understanding the Impact of Particle Size Variability on Incoming Testing Performance In the pharmaceutical manufacturing environment, ensuring the quality of raw materials, especially Active Pharmaceutical Ingredients (APIs) and excipients, is…

Understanding the Impact of Particle Size Variability During Supplier Changes Particle size variability can significantly affect the performance of Active Pharmaceutical Ingredients (APIs) and excipients, particularly during supplier changes. This…

Assessing Residual Solvent Excursions During Stability Investigations: A Comprehensive Guide Residual solvent excursions during stability studies can significantly impact the quality of active pharmaceutical ingredients (APIs) and subsequently affect regulatory…

Understanding How Particle Size Variability Affects Performance in Deviation Investigations Particle size variability in active pharmaceutical ingredients (APIs) can present significant challenges in pharmaceutical manufacturing, often leading to batch rejection…

Impact of Particle Size Variability on Regulatory Inspection Performance and Prevention Strategies In the highly regulated pharmaceutical industry, maintaining the quality of active pharmaceutical ingredients (APIs) and excipients is crucial…

Addressing Polymorphic Form Inconsistency in Incoming Testing: A Comprehensive Investigation Guide In pharmaceutical manufacturing, polymorphic forms of Active Pharmaceutical Ingredients (APIs) play a crucial role in determining product quality and…

Investigating Impurity Profile Drift After Supplier Change: A Practical Guide In the pharmaceutical manufacturing landscape, supply chain changes can pose significant quality risks. A recent scenario has surfaced where an…

Investigating API Assay Variability that Exceeds Trend Limits During Regulatory Inspections During a regulatory inspection, finding that API assay variability exceeds established trend limits can trigger significant concern. This situation…

Investigative Approach to Addressing API Stability Failures During Supplier Changes When changing suppliers for Active Pharmaceutical Ingredients (APIs), unforeseen stability failures can jeopardize product integrity, potentially leading to batch rejection…